Van Diest Capital, LLC
Source: SEC Form 13F · as of Mar 2026Van Diest Capital, LLC holds 15 biotech & pharma companies tracked by BioSniper, totaling $9.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$9.1M
| Company | Shares | Value |
|---|---|---|
| PMPhilip Morris International Inc | 9,298 | $1.5M |
| ELVElevance Health Inc. | 4,388 | $1.3M |
| LLYELI LILLY & Co | 1,060 | $974K |
| JNJJOHNSON & JOHNSON | 3,842 | $939K |
| IQVIQVIA Holdings Inc. | 4,293 | $732K |
| AMGNAMGEN INC | 1,664 | $586K |
| CORCencora Inc. | 1,734 | $545K |
| MCKMcKesson Corporation | 535 | $463K |
| BMYBRISTOL MYERS SQUIBB CO | 5,808 | $352K |
| NVSNovartis AG | 2,181 | $333K |
| CAHCardinal Health Inc. | 1,433 | $303K |
| ABBVAbbVie Inc. | 1,328 | $289K |
| GILDGILEAD SCIENCES, INC. | 2,052 | $286K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,777 | $264K |
| NVONovo Nordisk A/S | 5,958 | $219K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.